• Consensus Rating: Moderate Buy
  • Consensus Price Target: $130.25
  • Forecasted Upside: 23.17%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$105.75
▼ -1.03 (-0.96%)

This chart shows the closing price for TRNS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Transcat Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TRNS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRNS

Analyst Price Target is $130.25
▲ +23.17% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Transcat in the last 3 months. The average price target is $130.25, with a high forecast of $156.00 and a low forecast of $110.00. The average price target represents a 23.17% upside from the last price of $105.75.

This chart shows the closing price for TRNS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 5 investment analysts is to moderate buy stock in Transcat. This rating has held steady since April 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/25/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/23/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/21/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/20/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/12/2024Craig HallumBoost TargetBuy ➝ Buy$113.00 ➝ $125.00
10/30/2024Northland SecuritiesLower TargetMarket Perform ➝ Market Perform$130.00 ➝ $110.00
10/30/2024OppenheimerReiterated RatingOutperform ➝ Outperform$155.00 ➝ $130.00
10/30/2024Craig HallumLower TargetBuy ➝ Buy$138.00 ➝ $113.00
10/29/2024HC WainwrightReiterated RatingBuy ➝ Buy$156.00 ➝ $156.00
7/31/2024Craig HallumLower TargetBuy ➝ Buy$150.00 ➝ $138.00
7/30/2024HC WainwrightReiterated RatingBuy ➝ Buy$156.00 ➝ $156.00
5/22/2024Northland CapmkDowngradeStrong-Buy ➝ Hold
5/22/2024OppenheimerBoost TargetOutperform ➝ Outperform$125.00 ➝ $160.00
5/22/2024Northland SecuritiesDowngradeOutperform ➝ Market Perform
5/22/2024HC WainwrightBoost TargetBuy ➝ Buy$124.00 ➝ $156.00
4/18/2024OppenheimerReiterated RatingOutperform ➝ Outperform$120.00 ➝ $125.00
4/16/2024HC WainwrightReiterated RatingBuy ➝ Buy$124.00
1/31/2024HC WainwrightBoost TargetBuy ➝ Buy$108.00 ➝ $124.00
11/1/2023HC WainwrightBoost TargetBuy ➝ Buy$106.00 ➝ $108.00
10/17/2023OppenheimerInitiated CoverageOutperform$110.00
9/5/2023Craig HallumBoost Target$103.00 ➝ $112.00
8/7/2023HC WainwrightBoost TargetBuy ➝ Buy$102.00 ➝ $106.00
8/1/2023HC WainwrightReiterated RatingBuy ➝ Buy$102.00
5/24/2023Craig HallumBoost Target$92.00 ➝ $103.00
5/24/2023Northland SecuritiesBoost Target$100.00 ➝ $110.00
5/24/2023HC WainwrightBoost Target$96.00 ➝ $102.00
2/2/2023Roth CapitalBoost TargetBuy$80.00 ➝ $94.00
2/1/2023Craig HallumBoost TargetBuy$81.00 ➝ $92.00
2/1/2023Northland SecuritiesBoost TargetOutperform$90.00 ➝ $100.00
2/1/2023HC WainwrightBoost TargetBuy$88.00 ➝ $96.00
11/2/2022HC WainwrightBoost TargetBuy$85.00 ➝ $88.00
9/15/2022Northland SecuritiesInitiated CoverageOutperform$100.00
8/3/2022HC WainwrightBoost TargetBuy$77.00 ➝ $85.00
7/12/2022HC WainwrightLower TargetBuy$85.00 ➝ $77.00
6/2/2022HC WainwrightLower TargetBuy$105.00 ➝ $85.00
5/26/2022Roth CapitalLower TargetBuy$97.00 ➝ $80.00
5/25/2022Craig HallumLower TargetBuy$94.00 ➝ $81.00
12/20/2021HC WainwrightBoost TargetBuy$95.00 ➝ $105.00
11/4/2021Craig HallumBoost TargetBuy$72.00 ➝ $94.00
11/4/2021HC WainwrightBoost TargetBuy$73.00 ➝ $95.00
7/29/2021Craig HallumBoost TargetBuy$62.00 ➝ $72.00
7/29/2021Roth CapitalBoost TargetBuy$60.00 ➝ $70.00
7/29/2021HC WainwrightBoost TargetBuy$66.00 ➝ $73.00
5/26/2021Roth CapitalBoost TargetBuy$45.00 ➝ $60.00
5/20/2021Craig HallumBoost TargetBuy$49.00 ➝ $62.00
5/20/2021B. RileyBoost TargetBuy$56.00 ➝ $61.00
5/20/2021HC WainwrightBoost TargetBuy$48.00 ➝ $66.00
5/19/2021SidotiUpgradeNeutral ➝ Buy$60.00
4/27/2021B. RileyBoost TargetBuy$49.00 ➝ $56.00
3/29/2021SidotiDowngradeBuy ➝ Neutral$54.00
3/8/2021Colliers SecuritiesReiterated RatingBuy$43.50
2/4/2021Roth CapitalBoost TargetBuy$35.00 ➝ $45.00
2/4/2021Craig HallumBoost TargetBuy$36.00 ➝ $49.00
2/4/2021B. RileyBoost TargetBuy$41.00 ➝ $49.00
2/4/2021HC WainwrightBoost TargetBuy$42.00 ➝ $48.00
1/19/2021HC WainwrightInitiated CoverageBuy$42.00
1/14/2021B. RileyBoost TargetBuy$36.00 ➝ $41.00
9/17/2020B. RileyInitiated CoverageBuy$36.00
7/22/2020B. RileyInitiated CoverageBuy$35.00
7/16/2020Craig HallumInitiated CoverageBuy$36.00
6/15/2020B. RileyInitiated CoverageBuy$35.00
1/15/2020SidotiInitiated CoverageBuy$42.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.74 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 11 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/25/2024
  • 9 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2024
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2024
  • 10 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
8/23/2024
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2024
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2024
  • 8 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
11/21/2024
  • 7 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/21/2024

Current Sentiment

  • 7 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Transcat logo
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
Read More

Today's Range

Now: $105.75
Low: $104.73
High: $107.53

50 Day Range

MA: $110.27
Low: $95.41
High: $132.70

52 Week Range

Now: $105.75
Low: $94.29
High: $147.12

Volume

96,534 shs

Average Volume

55,399 shs

Market Capitalization

$972.79 million

P/E Ratio

53.41

Dividend Yield

N/A

Beta

0.7

Frequently Asked Questions

What sell-side analysts currently cover shares of Transcat?

The following Wall Street research analysts have issued stock ratings on Transcat in the last year: Craig Hallum, HC Wainwright, Northland Capmk, Northland Securities, Oppenheimer Holdings Inc., StockNews.com, and TheStreet.
View the latest analyst ratings for TRNS.

What is the current price target for Transcat?

0 Wall Street analysts have set twelve-month price targets for Transcat in the last year. Their average twelve-month price target is $130.25, suggesting a possible upside of 23.2%. HC Wainwright has the highest price target set, predicting TRNS will reach $156.00 in the next twelve months. Northland Securities has the lowest price target set, forecasting a price of $110.00 for Transcat in the next year.
View the latest price targets for TRNS.

What is the current consensus analyst rating for Transcat?

Transcat currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for TRNS.

What other companies compete with Transcat?

How do I contact Transcat's investor relations team?

Transcat's physical mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company's listed phone number is (585) 352-7777 and its investor relations email address is [email protected]. The official website for Transcat is www.transcat.com. Learn More about contacing Transcat investor relations.